Eli Lilly and Company (LLY) Stock Analysis

Eli Lilly and Company (LLY) Stock Analysis — AI Research | MarketCI

LLY

Market Closed

Eli Lilly and Company

NYSEHealthcare Drug Manufacturers - General

47.00K employees

CEO: David A. Ricks

Founded: 1972

$1,098.13

+$0.00(+NaN%)

Market Cap

1.03T

Beta

0.52

52W Range

N/A

Dividend Yield

0.63%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

LLY Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for LLY built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$497.85

AI Price Target

Machine learning • Price prediction

$1,047.01

Market Sentiment

News & social media analysis

0.39

Value Investor Price

Classic value analysis

$80.55

Financial Health

Bankruptcy risk assessment

8.33

Quality Score

Financial strength rating

6.00

AI Investment Grade

Deep analysis of filings & news

78.00

Key Investment Highlights

Important factors affecting LLY investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

69.05% Good

Conditions Met

29.00/42.00

Due Diligence Score

69.05%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions